Get the Stockscreener App
8.63
0.70%
+0.06
After Hours:
8.55
-0.08
-0.93%
Voyager Therapeutics Inc Stock (VYGR) Forecast
The Voyager Therapeutics Inc (VYGR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $8.6548, representing a +0.29% increase from the current price of $8.63. The highest analyst price target is $12.82, and the lowest is $4.4938.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VYGR Price Target
Average 6.4444
(-25.33% Downside)
Is Voyager Therapeutics Inc (VYGR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 54.17 | Neutral |
| STOCH(9,6) | 45.42 | Neutral |
| STOCHRSI(14) | 71.78 | Neutral |
| MACD(12,26) | 0.0241 | Buy |
| ADX(14) | 15.79 | Neutral |
| William %R | -31.76 | Neutral |
| CCI(14) | 28.54 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.613
Buy
|
8.4968
Buy
|
| MA20 |
8.197
Buy
|
8.439
Buy
|
| MA50 |
8.7694
Sell
|
8.4834
Buy
|
| MA100 |
8.46
Buy
|
8.4177
Buy
|
| MA200 |
8.1675
Buy
|
8.4413
Buy
|
Buy: 9
Sell: 1
Neutral: 0
Summary: Buy
According to our latest analysis, VYGR could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 1 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on VYGR, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 54.17 indicates that VYGR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 45.42 indicates that VYGR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 71.78 indicates that VYGR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 15.79 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 28.54 indicates that VYGR is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term VYGR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Voyager Therapeutics Inc financial reports and earnings history, Voyager Therapeutics Inc (VYGR) stock could reach $7.9924 by 2030, $15.23 by 2040 and $47.06 by 2050. See the projected annual prices until 2050 of the Voyager Therapeutics Inc stock below:
- Voyager Therapeutics Inc (VYGR) is expected to reach an average price of $6.1819 in 2035, with a high prediction of $6.6695 and a low estimate of $6.3919. This indicates an $-28.37% rise from the last recorded price of $8.63.
- Voyager Therapeutics Inc (VYGR) stock is projected to chart a bullish course in 2040, with an average price target of $15.94, representing an $84.65% surge from its current level. The forecast ranges from a conservative $15.63 to a sky-high $15.23.
- Our analysts predict Voyager Therapeutics Inc (VYGR) to jump 241.13% by 2045, soaring from $29.72 to an average price of $29.44, potentially reaching $29.38. While $29.72 is the low estimate, the potential upside is significant.
- Voyager Therapeutics Inc (VYGR) stock is expected to climb by 2050, reaching an average of $42.72, a $394.99% jump from its current level. However, a wide range of estimates exists, with high and low targets of $47.06 and $45.00, respectively, highlighting the market's uncertainty.
Voyager Therapeutics Inc Stock (VYGR) Year by Year Forecast
Voyager Therapeutics Inc Stock (VYGR) Price Forecast for 2024
Our forecast for VYGR stock price in 2024 now indicates an average price target of $6.4444 with a high forecast of $12.82 and a low forecast of $0.073. The average prediction reflects an decrease of -25.33% from the last recorded price of $8.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $11.22 | $4.4938 | $12.82 | +30.03% |
| July, 2024 | $6.6515 | $6.3515 | $12.57 | -22.93% |
| August, 2024 | $4.2703 | $3.7634 | $7.9334 | -50.52% |
| September, 2024 | $2.7791 | $0.4431 | $4.5312 | -67.80% |
| October, 2024 | $0.3511 | $0.073 | $3.4851 | -95.93% |
| November, 2024 | $0.0127 | $0.3242 | $1.4664 | -99.85% |
| December, 2024 | $0.8935 | $1.5194 | $0.4794 | -89.65% |
Voyager Therapeutics Inc Stock (VYGR) Price Forecast for 2025
Voyager Therapeutics Inc Stock (VYGR) is expected to reach an average price of $3.5016 in 2025, with a high prediction of $6.0582 and a low estimate of $0.9451. This indicates an -59.42% fall from the last recorded price of $8.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.3737 | $1.0256 | $0.7897 | -84.08% |
| February, 2025 | $3.6099 | $1.2318 | $2.4899 | -58.17% |
| March, 2025 | $3.9061 | $1.868 | $1.9861 | -54.74% |
| April, 2025 | $5.2363 | $3.8301 | $6.0582 | -39.32% |
| May, 2025 | $3.6425 | $4.1025 | $5.1203 | -57.79% |
| June, 2025 | $2.0686 | $3.0286 | $3.3506 | -76.03% |
| July, 2025 | $0.3689 | $1.5831 | $1.1408 | -95.73% |
| August, 2025 | $0.7151 | $0.9451 | $0.8871 | -91.71% |
| September, 2025 | $2.2912 | $1.5491 | $2.0812 | -73.45% |
| October, 2025 | $2.5315 | $1.6974 | $1.6453 | -70.67% |
| November, 2025 | $2.4876 | $2.1936 | $2.4704 | -71.17% |
| December, 2025 | $2.3479 | $2.0938 | $2.2617 | -72.79% |
Voyager Therapeutics Inc Stock (VYGR) Price Forecast for 2026
The predicted value for Voyager Therapeutics Inc (VYGR) in 2026 is set at an average of $5.4709. Estimates vary from a peak of $8.2199 to a trough of $2.7219, indicating an -36.61% surge from the present price of $8.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.374 | $2.7219 | $4.054 | -49.32% |
| February, 2026 | $3.9302 | $4.5602 | $4.3662 | -54.46% |
| March, 2026 | $4.0464 | $4.4463 | $4.5283 | -53.11% |
| April, 2026 | $5.6266 | $4.1404 | $4.9466 | -34.80% |
| May, 2026 | $6.6828 | $6.7307 | $6.3228 | -22.56% |
| June, 2026 | $7.319 | $7.3649 | $7.2009 | -15.19% |
| July, 2026 | $7.3392 | $7.2511 | $7.1971 | -14.96% |
| August, 2026 | $7.0254 | $7.5254 | $7.4713 | -18.59% |
| September, 2026 | $7.6656 | $7.3494 | $7.4556 | -11.17% |
| October, 2026 | $8.1168 | $8.1697 | $8.1677 | -5.95% |
| November, 2026 | $8.028 | $8.218 | $8.2199 | -6.98% |
| December, 2026 | $8.4782 | $7.992 | $8.0782 | -1.76% |
Voyager Therapeutics Inc Stock (VYGR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Voyager Therapeutics Inc (VYGR) is $5.1799, with a high forecast of $8.4122 and a low forecast of $1.9476. This indicates an -39.98% decrease from the last price of $8.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.1644 | $6.9403 | $8.4122 | -16.98% |
| February, 2027 | $7.5305 | $7.3625 | $7.3155 | -12.74% |
| March, 2027 | $7.6508 | $7.8185 | $7.6086 | -11.35% |
| April, 2027 | $7.557 | $7.737 | $7.6189 | -12.43% |
| May, 2027 | $7.1131 | $7.5591 | $7.461 | -17.58% |
| June, 2027 | $6.4734 | $6.4893 | $6.7672 | -24.99% |
| July, 2027 | $2.4095 | $2.4055 | $3.2574 | -72.08% |
| August, 2027 | $2.4057 | $1.9476 | $1.5317 | -72.12% |
| September, 2027 | $3.6559 | $3.0798 | $3.2929 | -57.64% |
| October, 2027 | $4.5621 | $3.72 | $4.1621 | -47.14% |
| November, 2027 | $2.8483 | $3.5183 | $3.3862 | -67.00% |
| December, 2027 | $3.1685 | $2.9445 | $2.3623 | -63.28% |
Voyager Therapeutics Inc Stock (VYGR) Price Forecast for 2028
In 2028, Voyager Therapeutics Inc (VYGR) is projected to reach an average price of $3.3903, with a high projection of $6.7552 and a low estimate of $0.0253. This indicates an -60.72% fall from the last price of $8.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.4747 | $3.2447 | $3.0426 | -71.32% |
| February, 2028 | $3.0309 | $2.654 | $2.4168 | -64.88% |
| March, 2028 | $3.5911 | $3.159 | $3.3811 | -58.39% |
| April, 2028 | $3.1173 | $3.5273 | $3.1992 | -63.88% |
| May, 2028 | $2.8875 | $2.6994 | $2.6513 | -66.54% |
| June, 2028 | $0.8563 | $0.4563 | $2.5113 | -90.08% |
| July, 2028 | $0.4499 | $0.4458 | $1.4182 | -94.79% |
| August, 2028 | $0.4601 | $0.7839 | $0.677 | -94.67% |
| September, 2028 | $0.1537 | $0.2963 | $0.5359 | -98.22% |
| October, 2028 | $0.3675 | $0.0253 | $0.5837 | -95.74% |
| November, 2028 | $3.8473 | $0.1835 | $6.7552 | -55.42% |
| December, 2028 | $4.0811 | $3.4452 | $6.6652 | -52.71% |
Voyager Therapeutics Inc Stock (VYGR) Price Forecast for 2029
The 2029 price forecast for Voyager Therapeutics Inc Stock (VYGR) is $3.4742 on average, with a high prediction of $6.8901 and a low estimate of $0.0583. This represents an -59.74% decrease from the previous price of $8.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.1309 | $1.405 | $4.2421 | -75.31% |
| February, 2029 | $2.6447 | $1.4228 | $2.7447 | -69.35% |
| March, 2029 | $1.0586 | $1.0286 | $3.3166 | -87.73% |
| April, 2029 | $0.6324 | $0.0864 | $1.4245 | -92.67% |
| May, 2029 | $0.2278 | $0.0583 | $1.1083 | -97.36% |
| June, 2029 | $1.176 | $0.1141 | $1.246 | -86.37% |
| July, 2029 | $2.1498 | $0.8479 | $2.5898 | -75.09% |
| August, 2029 | $1.1596 | $0.8277 | $5.4658 | -86.56% |
| September, 2029 | $2.2134 | $1.0774 | $2.2734 | -74.35% |
| October, 2029 | $3.2232 | $2.3453 | $4.7832 | -62.65% |
| November, 2029 | $1.857 | $1.6401 | $4.9451 | -78.48% |
| December, 2029 | $7.71 | $1.6529 | $6.8901 | -10.66% |
Voyager Therapeutics Inc Stock (VYGR) Price Forecast for 2030
Voyager Therapeutics Inc Stock (VYGR) is expected to reach an average price of $12.46 in 2030, with a high forecast of $20.37 and a low forecast of $4.5547. This signifies an +44.39% surge from the last price of $8.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.5104 | $9.2294 | $7.9924 | -12.97% |
| February, 2030 | $5.9028 | $4.5547 | $4.0028 | -31.60% |
| March, 2030 | $9.8152 | $7.7709 | $8.2652 | +13.73% |
| April, 2030 | $13.13 | $11.16 | $10.93 | +52.12% |
| May, 2030 | $13.38 | $13.66 | $13.28 | +55.02% |
| June, 2030 | $15.19 | $15.32 | $14.54 | +76.02% |
| July, 2030 | $15.72 | $14.73 | $15.24 | +82.16% |
| August, 2030 | $15.59 | $16.36 | $15.45 | +80.69% |
| September, 2030 | $14.89 | $15.80 | $15.53 | +72.54% |
| October, 2030 | $15.99 | $15.86 | $17.05 | +85.24% |
| November, 2030 | $21.55 | $16.54 | $17.63 | +149.69% |
| December, 2030 | $20.50 | $20.27 | $20.37 | +137.55% |
4.27%
2.59%
Cap:
|
Volume (24h):